Resultados de la búsqueda 261-270 of 12424 for Familial hypercholesterolaemia

  1. Nivel de colesterol alto - Médicos y departamentos - Mayo Clinic

    Boletín informativo: Mayo Clinic Health Letter — Edición digital · Mayo Clinic Family Health Book (Libro de Mayo Clinic sobre la salud familiar), 5.ª edición ...

  2. Hematología - Ensayos clínicos - Mayo Clinic

    All study subjects will receive acalabrutinib, durvalumab, and venetoclax. Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small ...

  3. Hematología - Ensayos clínicos - Mayo Clinic

    Usual treatment after a complete response may include observation or high dose chemotherapy followed by an autologous stem cell transplant, however, it is not ...

  4. Hematología - Ensayos clínicos - Mayo Clinic

    All study subjects will receive acalabrutinib, durvalumab, and venetoclax. Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small ...

  5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The primary purpose of this study is to standardize the collection of demographic, clinical, and imaging data, and biosamples for a large high-risk familial ...

  6. Médicos y departamentos

    Hyperglycemia (high blood glucose). American Diabetes Association. https://www.diabetes.org/healthy-living/medication-treatments/blood-glucose-testing-and- ...

  7. Hematología - Ensayos clínicos - Mayo Clinic

    All study subjects will receive acalabrutinib, durvalumab, and venetoclax. Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small ...

  8. Cirugía - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to combine recent advances in ultrasound imaging, specifically an endonasal transducer array and contrast enhanced ultrasound, ...

  9. Salud del adulto Noticias de la Mayo Clinic

    News. noviembre 2025. Why Thanksgiving is the perfect time to share family health history Nov. 25, 2025, 04:01 p.m. CDT ...

  10. Hematología - Ensayos clínicos - Mayo Clinic

    All study subjects will receive acalabrutinib, durvalumab, and venetoclax. Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small ...